Modulated gut microbiota by increasing Akkermansia spp. and SCFA levels; ↓ inflammation by downregulating TNF-α, IL-6, and TLR-4; counteracted endotoxaemia; ↓ hepatic triglyceride accumulation; protected against NAFLD progression. The gene discussed is TNF; the disease is metabolic dysfunction-associated steatotic liver disease.